MedPath
NMPA Approval

Galanthamine Hydrobromide Orally Disintegrating Tablets

国药准字H20244023

June 18, 2024

Drug Information

氢溴酸加兰他敏口腔崩解片

片剂

12mg(按C₁₇H₂₁NO₃计)

化学药品

June 18, 2024

Company Information

Applicant Company

广东省东莞市松山湖园区工业北路1号

Manufacturing Company

湖北省宜昌宜都市滨江路38号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

氢溴酸加兰他敏口腔崩解片 - NMPA 批准文号 | MedPath